KITE

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KITE

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next >>

Date	Time	Source	Headline	Symbol	Company
07/11/2024	12:21PM	iHub Newswire	FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
12/13/2016	8:30AM	Business Wire	Kite Pharma & Vitruvian Networks Enter Strategic Partnership to Develop Best-In-Class Logistics & Data Analytics Software for...	NASDAQ:KITE	Kite Pharma, Inc.
12/12/2016	8:30AM	Business Wire	Kite Pharma Announces Publication of T-Cell Therapy Targeting Mutant KRAS in Cancer by the National Cancer Institute (NCI) in...	NASDAQ:KITE	Kite Pharma, Inc.
12/06/2016	10:30AM	Business Wire	Kite Pharma Presents Results of Multi-Center Pivotal ZUMA-1 Trial of Axicabtagene Ciloleucel (KTE-C19) in Aggressive Non-Hodg...	NASDAQ:KITE	Kite Pharma, Inc.
12/04/2016	10:30PM	Business Wire	Kite Pharma Initiates Rolling Submission of U.S. Biologics License Application (BLA) for KTE-C19, its Investigational anti-CD...	NASDAQ:KITE	Kite Pharma, Inc.
12/04/2016	9:00PM	Business Wire	Kite Pharma Reports 82 Percent of Patients Achieved Complete Remission in Preliminary Analysis from Phase 1 ZUMA-3 & ZUMA-4 T...	NASDAQ:KITE	Kite Pharma, Inc.
12/01/2016	8:30AM	Business Wire	Kite Pharma Appoints Jian Irish, PhD as Senior Vice President of Supply Chain	NASDAQ:KITE	Kite Pharma, Inc.
11/29/2016	5:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KITE	Kite Pharma, Inc.
11/21/2016	9:19AM	Business Wire	Kite Pharma to Present Interim Results from the ZUMA-1 Pivotal Trial of KTE-C19 in a Late-Breaking Session at the 2016 Americ...	NASDAQ:KITE	Kite Pharma, Inc.
11/14/2016	6:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KITE	Kite Pharma, Inc.
11/09/2016	9:06AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KITE	Kite Pharma, Inc.
11/09/2016	9:00AM	Business Wire	Kite Pharma Reports Third Quarter 2016 Financial Results	NASDAQ:KITE	Kite Pharma, Inc.
11/09/2016	8:58AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:KITE	Kite Pharma, Inc.
11/03/2016	9:28AM	Business Wire	Kite Pharma to Present KTE-C19 Data from Interim Analysis of the ZUMA-1 Pivotal Trial in Patients with Chemorefractory Primar...	NASDAQ:KITE	Kite Pharma, Inc.
11/02/2016	8:30AM	Business Wire	Kite Pharma to Report Third Quarter 2016 Financial Results on November 9, 2016	NASDAQ:KITE	Kite Pharma, Inc.
10/28/2016	8:30AM	Business Wire	Kite Pharma to Present at November 2016 Investor Conferences	NASDAQ:KITE	Kite Pharma, Inc.
10/19/2016	8:41AM	Business Wire	Kite Pharma Details KTE-C19 Launch Preparedness and Near-Term, Next Generation CAR/TCR Product Candidates at Investor Day	NASDAQ:KITE	Kite Pharma, Inc.
10/13/2016	8:30AM	Business Wire	Kite Pharma Appoints Chris Nowers as Head of Europe to Lead Commercial Operations & Advance the Company’s CAR/TCR Therapy P...	NASDAQ:KITE	Kite Pharma, Inc.
10/11/2016	8:30AM	Business Wire	Kite Pharma to Host Investor Day on October 18, 2016 Spotlighting an Industry-Leading CAR/TCR Pipeline, Next Generation Resea...	NASDAQ:KITE	Kite Pharma, Inc.
10/07/2016	10:59AM	Business Wire	Kite Pharma Presents 12-Month Follow-Up Data from ZUMA-1 Phase 1 at the European Society for Medical Oncology (ESMO) Annual C...	NASDAQ:KITE	Kite Pharma, Inc.
10/06/2016	8:30AM	Business Wire	Kite Pharma Initiates Phase 1b/2 Combination Study for KTE-C19 & Atezolizumab in Patients with Refractory Diffuse Large B-cel...	NASDAQ:KITE	Kite Pharma, Inc.
10/05/2016	7:45PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KITE	Kite Pharma, Inc.
10/04/2016	4:24PM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:KITE	Kite Pharma, Inc.
09/30/2016	9:00AM	PR Newswire (US)	Biotechs and the Advancements in Cancer Oriented Clinical Trials	NASDAQ:KITE	Kite Pharma, Inc.
09/29/2016	4:05PM	Business Wire	Kite Pharma Names Christine Cassiano as Senior Vice President of Corporate Communications and Investor Relations	NASDAQ:KITE	Kite Pharma, Inc.
09/28/2016	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KITE	Kite Pharma, Inc.
09/26/2016	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KITE	Kite Pharma, Inc.
09/26/2016	4:01PM	Business Wire	Kite Pharma Announces Positive Topline KTE-C19 Data from ZUMA-1 Pivotal Trial in Patients with Aggressive Non-Hodgkin Lymphom...	NASDAQ:KITE	Kite Pharma, Inc.
09/20/2016	4:05PM	Business Wire	Kite Pharma Announces Exclusive License with the National Institutes of Health for Multiple Neoantigen Directed T-Cell Recept...	NASDAQ:KITE	Kite Pharma, Inc.
09/02/2016	6:35PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KITE	Kite Pharma, Inc.